Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 20, 2022

SELL
$255.51 - $362.11 $152,539 - $216,179
-597 Closed
0 $0
Q4 2021

Jan 21, 2022

SELL
$351.38 - $448.68 $5,973 - $7,627
-17 Reduced 2.77%
597 $225,000
Q3 2021

Oct 29, 2021

BUY
$372.64 - $458.3 $372 - $458
1 Added 0.16%
614 $253,000
Q2 2021

Aug 02, 2021

BUY
$294.17 - $371.65 $180,326 - $227,821
613 New
613 $227,000
Q1 2021

Apr 29, 2021

SELL
$249.67 - $299.48 $162,285 - $194,662
-650 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$222.0 - $252.62 $59,274 - $67,449
-267 Reduced 29.12%
650 $163,000
Q3 2020

Nov 03, 2020

BUY
$175.56 - $226.45 $160,988 - $207,654
917 New
917 $207,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Pinnacle Wealth Planning Services, Inc. Portfolio

Follow Pinnacle Wealth Planning Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Wealth Planning Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Wealth Planning Services, Inc. with notifications on news.